Comparison of the Abbott m2000 HIV-1 real-time and Roche AMPLICOR monitor v1.5 HIV-1 assays on plasma specimens from Rakai, Uganda

International Journal of STD and AIDS

Volumn 22, Issue 7, 2011, Pages 373-375

  Ssebugenyi, I ^a   Kizza, A ^a   Mpoza, B ^a   Aluma, G ^a   Boaz, I ^a   Newell, K ^b,c   Laeyendecker, O ^c,d   Shott, J P ^b,c   Serwadda, D ^e   Reynolds, S J ^c,d  

^a Kalisizo Rakai ^*  (Uganda)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MAKERERE UNIVERSITY   (Uganda)

Author keywords

Antiretroviral treatment; HIV 1; Monitoring; Realtime polymerase chain reaction; Resource limited; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; ASSAY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION; VIRUS LOAD;

ANTI-HIV AGENTS; DRUG MONITORING; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; PLASMA; PREDICTIVE VALUE OF TESTS; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; UGANDA; VIRAL LOAD;

EID: 79960160096     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2009.009526     Document Type: Article

References (12)

1. Chaiwarith R, Wachirakaphan C, Kotarathititum W, et al. Sensitivity and specificity of using CD4+ measurement and clinical evaluation to determine antiretroviral treatment failure in Thailand. Int J Infect Dis 2007;11:413-6
2. Mee P, Fielding KL, Charalambous S, et al. Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South Africa. AIDS 2008;22:1971-7
3. Mellors JW, Rinaldo CR Jr, Gupta P, et al. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70
4. Moore DM, Mermin J, Awor A, et al. Performance of immunologic responses in predicting viral load suppression: implications for monitoring patients in resource-limited settings. J Acquir Immune Defic Syndr 2006;43:436-9
5. Reynolds SJ, Nakigozi G, Newell K, et al. Failure of immunologic criteria to appropriately identify antiretroviral treatment failure in Uganda. AIDS 2009;23:697-700
6. Gueudin M, Plantier JC, Lemee V, et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007;44:500-5
7. Swanson P, Huang S, Holzmayer V, et al. Performance of the automated Abbott RealTime HIV-1 assay on a genetically diverse panel of specimens from Brazil. J Virol Methods 2006;134:237-43
8. Swanson P, Soriano V, Devare SG, Hackett J Jr. Comparative performance of three viral load assays on human immunodeficiency virus type 1 (HIV-1) isolates representing group M (subtypes A to G) and group O: LCx HIV RNA quantitative, AMPLICOR HIV-1 MONITOR version 1.5, and Quantiplex HIV-1 RNA version 3.0. J Clin Microbiol 2001;39:862-70
9. Tang N, Huang S, Salituro J, et al. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J Virol Methods 2007;146:236-45
10. Conroy SA, Laeyendecker O, Redd AD, et al. Changes in the distribution of HIV-1 subtypes D and A in Rakai District, Uganda between 1994 and 2002. AIDS Res Hum Retroviruses 2010;10:1087-91
11. Marconi A, Balestrieri M, Comastri G, et al. Evaluation of the Abbott Real-Time HIV-1 quantitative assay with dried blood spot specimens. Clin Microbiol Infect 2009;15:93-7
12. Scott LE, Noble LD, Moloi J, et al. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J Clin Microbiol 2009;47:2209-17